RARA CRAFT DATABASE for FDA Medical Devices
510(k)K183562

FDA DEVICE FACTS

Powder-Free Nitrile Examination Glove (White Colored, Blue Colored, and Black Colored) Tested for Use with Chemotherapy Drugs

Encompass Industries Sdn. Bhd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 23, 2019PRODUCT CODELZC

Indications for use

A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. In addition, the glove was tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: The following chemotherapy drugs have been tested with the white glove: Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Cyclophosphamide (Cytoxan) 20.0mg/ml > 240 Doxorubicin Hydrochloride 2.0mg/ml > 240 Etoposide (Toposar) 20.0mg/ml > 240 Fluorouracil 50.0mg/ml > 240 Paclitaxel (Taxol) 6.0mg/ml > 240 Cisplatin 1.0mg/ml > 240 Dacarbazine (DTIC) 10.0mg/ml > 240 *Carmustine (BCNU) 3.3mg/ml 11.2 *Thiotepa (THT) 10.0mg/ml 25.2 *Please note that the following 2 drugs have extremely low permeation times:

1. Carmustine: 11.2 minutes

2. Thiotepa: 25.2 minutes Warning: Do not use with Carmustine (BCNU) and Thiotepa (THT). The following chemotherapy drugs have been tested with the blue glove: Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Cyclophosphamide (Cytoxan) 20.0mg/ml > 240 Doxorubicin Hydrochloride 2.0mg/ml > 240 Etoposide (Toposar) 20.0mg/ml > 240 Fluorouracil 50.0mg/ml > 240 Paclitaxel (Taxol) 6.0mg/ml > 240 Cisplatin 1.0mg/ml > 240 Dacarbazine (DTIC) 10.0mg/ml > 240 *Carmustine (BCNU) 3.3mg/ml 10.7 *Thiotepa (THT) 10.0mg/ml 21.5 *Please note that the following 2 drugs have extremely low permeation times:

1. Carmustine: 10.7 minutes

2. Thiotepa: 21.5 minutes Warning: Do not use with Carmustine (BCNU) and Thiotepa (THT). The following chemotherapy drugs have been tested with the black glove: Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Cyclophosphamide (Cytoxan) 20.0mg/ml > 240 Doxorubicin Hydrochloride 2.0mg/ml > 240 Etoposide (Toposar) 20.0mg/ml > 240 Fluorouracil 50.0mg/ml > 240 Paclitaxel (Taxol) 6.0mg/ml > 240 Cisplatin 1.0mg/ml > 240 Dacarbazine (DTIC) 10.0mg/ml > 240 *Carmustine (BCNU) 3.3mg/ml 11.0 *Thiotepa (THT) 10.0mg/ml 11.1 *Please note that the following 2 drugs have extremely low permeation times:

1. Carmustine: 11.0 minutes

2. Thiotepa: 11.1 minutes Warning: Do not use with Carmustine (BCNU) and Thiotepa (THT).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026